Menu Search
Equities

UCrest Bhd

UCREST:KLS

UCrest Bhd

Actions
Health CareHealth Care Providers
  • Price (MYR)0.125
  • Today's Change0.005 / 4.17%
  • Shares traded4.89m
  • 1 Year change-26.47%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in MYRIncome statement in MYRView more

Year on year UCrest Bhd grew revenues 21.62% from 13.56m to 16.49m while net income improved 4,782.06% from 100.90k to 4.93m.
Gross margin29.10%
Net profit margin29.87%
Operating margin29.96%
Return on assets9.83%
Return on equity13.15%
Return on investment13.12%
More ▼

Cash flow in MYRView more

In 2024, UCrest Bhd increased its cash reserves by 8.53%, or 1.50m. Cash Flow from Financing totalled 4.51m or 27.35% of revenues. In addition the company used 3.39m for operations while cash used for investing totalled 16.00k.
Cash flow per share0.0104
Price/Cash flow per share12.03
Book value per share0.0572
Tangible book value per share0.054
More ▼

Balance sheet in MYRView more

UCrest Bhd has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 19.14m.
Current ratio2.92
Quick ratio--
Total debt/total equity0.0043
Total debt/total capital0.0043
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.